Almost all patients with pancreatic cancer carry at least one of the known driving genes that are frequently mutated, oncogene K-RAS and tumour suppressor genes CDKN2A, TP53 and Smad4/DPC4 25, 26. This evidence concerns the gene CDKN2A and pancreatic neoplasm.